EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Who Pays for Chronic Disease Medicines? Socioeconomic Inequality in Catastrophic and Impoverishing Out-of-Pocket Spending on Medicines in Honduras, 2023–2024

Dely Ramirez, Lilian Sosa, Lupe Carolina Espinoza, Ery Jonathan Elvir Vallecillo, Karla Fernández-Norales

International Journal of Environmental Research and Public Health · 19.11.2026 · 23 (11) · 1431

DOI: 10.3390/ijerph23111431 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Environmental Research and Public Health, online erschienen am 19.11.2026. Verfasst von Dely Ramirez und 4 weiteren Autor:innen. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Medicines dominate out-of-pocket health spending in Central America, particularly for households requiring chronic treatment. Using 8746 households from Honduras’s 2023–2024 National Household Income and Expenditure Survey and design-based methods, we assessed catastrophic spending on medicines (10% and 25% of consumption; 40% of capacity to pay), impoverishment and socioeconomic inequality, using concentration indices, decompositions and two-part models of the expenditure share. Medicines accounted for 54.8% of out-of-pocket health spending. Overall, 8.2% (95% CI: 7.1–9.3%) of the population incurred catastrophic spending at 10%: 23.4% in households using chronic-disease medicines versus 3.0% in other households, a gap that is partly mechanical. With households ranked by total consumption, catastrophic spending appeared concentrated among better-off households (Erreygers index 0.035), but this gradient disappeared when ranking by consumption net of health spending (−0.019), under which catastrophic spending at higher thresholds and impoverishment (1.6% of the population) were concentrated among the poor. Use of chronic-disease medicines was pro-rich under both rankings, and socioeconomic differences operated through whether households paid at all rather than through the share paid. Unmet need is one plausible explanation, alongside differences in diagnosis and prevalence.

Zitieren

APA

Ramirez, D., Sosa, L., Espinoza, L. C., Vallecillo, E. J. E., & Fernández-Norales, K. (2026). Who Pays for Chronic Disease Medicines? Socioeconomic Inequality in Catastrophic and Impoverishing Out-of-Pocket Spending on Medicines in Honduras, 2023–2024. International Journal of Environmental Research and Public Health, 23(11), 1431. https://doi.org/10.3390/ijerph23111431

Vancouver

Ramirez D, Sosa L, Espinoza LC, Vallecillo EJE, Fernández-Norales K. Who Pays for Chronic Disease Medicines? Socioeconomic Inequality in Catastrophic and Impoverishing Out-of-Pocket Spending on Medicines in Honduras, 2023–2024. International Journal of Environmental Research and Public Health. 2026;23(11):1431. doi:10.3390/ijerph23111431

BibTeX
@article{Ramirez2026,
  author = {Ramirez, Dely and Sosa, Lilian and Espinoza, Lupe Carolina and Vallecillo, Ery Jonathan Elvir and Fernández-Norales, Karla},
  title = {Who Pays for Chronic Disease Medicines? Socioeconomic Inequality in Catastrophic and Impoverishing Out-of-Pocket Spending on Medicines in Honduras, 2023–2024},
  journal = {International Journal of Environmental Research and Public Health},
  year = {2026},
  volume = {23},
  number = {11},
  pages = {1431},
  doi = {10.3390/ijerph23111431}
}
Kostenlos starten →